Every dollar raised in Quebec by the Canadian Cancer Society CIBC Run for the Cure will be matched by CQDM Montreal, June 20, 2018 – The Canadian Cancer Society (CCS), a leader in breast cancer research funding in the province and Quebec’s largest cancer group offering support services to people living with breast cancer, is proud to announce…
BOSTON, JUNE 6, 2018 – CQDM is pleased to announce the funding of a new $1.1 million research project in conjunction with financial contributions from lead industrial partner, Immune Biosolutions, and co-funding from: Cancer Research Society, Mitacs, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke and TransferTech. The funds will be used by the Université…
BOSTON, June 6, 2018 – CQDM is pleased to announce that Takeda Pharmaceutical Company Limited and Roche have joined the CQDM as new members. Members leverage the consortium’s strength to identify and finance innovative biopharmaceutical research projects from across Canada, with the ultimate goal of enabling the development of better treatments for patients. « Je salue…
QUÉBEC city, March 29, 2018 – CQDM is pleased to announce the selection of a new Quantum Leap project jointly with Feldan Therapeutics for a total amount of $1.2M. The funds will be used for further development of a breakthrough drug delivery technology, in collaboration with Professor Frédéric Calon from Laval University. CQDM’s support for this…
On November 19th, 2018, CQDM celebrated its 10th Anniversary with 300 people involved in the life sciences field, including members from the pharmaceutical industry, scientists from academic research institutions, entrepreneurs, partners and government representatives. During this event, Diane Gosselin, President and CEO of CQDM, unveils a study carried out over the last 10 years, revealing…
CQDM and Brain Canada Inject $1 M in Top BC Biotech Firm AbCellera to Advance Discovery Platform for Next-Generation Antibody Therapeutics The program will leverage AbCellera’s high-throughput, single-cell screening platform to allow rapid identification of functional antibodies against complex membrane proteins. MONTREAL, January 12th, 2018– CQDM and Brain Canada are proud to announce the non-dilutive…
Rémi Quirion appointed member of CQDM’s Board Montreal, November 28th, 2017 – The Chairman of CQDM’s Board, Richard Fajzel, and the President and CEO of CQDM, Diane Gosselin, are pleased to announce the appointment of Rémi Quirion, Chief Scientist of Quebec on the CQDM’s Board. Rémi Quirion became Quebec’s first Chief Scientist in 2011. He is…
The CQDM is expanding its financing activities in all fields of biopharmaceutical research in Quebec Montréal, May 23 2017 – The CQDM is proud to be launching its new SynergiQc program, designed to stimulate industrial research in the biopharmaceutical field within academic settings and to create economic benefits for Quebec. SynergiQc aims to support Quebec companies, through the financing of academic research…
Summer Intership position – Administration and Accounting POSITION SUMMARY: The CQDM is looking for a student to assist the Vice President Finance and Administration with various administrative and accounting tasks. PRINCIPAL RESPONSIBILITIES: Bookkeeping; Assistance in the preparation of reports for the different levels of government (federal and provincial); Filing of documents; Assist with updating CQDM’s performance…
Montreal, March 24, 2017 – A project funded by CQDM and Brain Canada has resulted in the creation of NeuroCDRD, a new collaboration between the Centre for Drug Research and Development (CDRD), the Montreal Neurological Institute and Hospital at McGill University (MNI), and Merck. CQDM and Brain Canada, with financial support from Health Canada through the…